... Zatorski; Bram Verstockt; Jonathan Philip Segal Background: Inflammatory bowel disease (IBD) care and education might differ around Europe. Therefore, we conducted this European Variation In IBD PracticE suRvey (VIPER) to investigate potential differences between countries. Methods: This trainee-initiated...

...Welmoed K. van Deen; Carine Khalil; Nirupama N. Bonthala; Rebecca Gale; Devin B. Patel; Esther Warui; Gil Y. Melmed; Brennan M.R. Spiegel Background: Multiple biologics are available to treat inflammatory bowel disease (IBD), which can either be administered subcutaneously or intravenously...

... responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Biomarkers Inflammatory bowel diseases Treatment response Fecal lactoferrin Biologics Primary response to biologic induction...

... or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. NET Celiac disease Inflammatory bowel diseases Treatment Diagnosis...

...Benjamin Koslowsky; Betty Mazuz; Ami Ben-Ya’acov; Aliza Neumark; Ariella Bar-Gil Shitrit; Eran Goldin Background: The use of medical cannabis (MC) for inflammatory bowel diseases (IBDs) is expanding. Current evidence does not support the efficacy of MC for reducing inflammation in IBD patients...

... to in the content or advertisements. Inflammatory bowel diseases Crohn’s disease Ultrasonography Surgery Crohn’s disease (CD) is a dynamic process, meaning that it may change its form of presentation in the long-term period [ 1 ]. Approximately 30% of patients with CD develop strictures in 10 years...

... coronary disease completely reversible within 4–8 weeks. Inflammatory bowel diseases (IBD) are a group of diseases caused by the interaction between immune system, genetic, and environmental factors against intestinal mucosa. Both these syndromes are characterized by complex mechanisms involving...

... to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Inflammatory bowel diseases Ulcerative colitis Adalimumab Long-term efficacy Prednisolone Colectomy-free survival rate Ulcerative colitis (UC) is one of the 2...

..., and Polyols) diet on patients with irritable bowel syndrome (IBS), non-active inflammatory bowel diseases (IBD), and celiac disease (CD) on a gluten-free diet (GFD). Methods: Dietetic interventional prospective study. IBS, IBD, and CD subjects were evaluated to check if they fulfilled the Rome III criteria...

...M. Kolar; D. Duricova; M. Bortlik; V. Hruba; N. Machkova; K. Mitrova; K. Malickova; M. Lukas Jr.; Milan Lukas Background: The evidence on the efficacy and safety of biosimilar infliximab (IFX) in patients with inflammatory bowel diseases (IBD) is sparse. Methods: Consecutive IBD patients visiting...

..., instructions or products referred to in the content or advertisements. Dysbiosis Gnotobiotic animals Gut microbiota Inflammatory bowel diseases Probiotics Host-microbe interactions and their consequences are in the viewfinder of modern research, and gut microbiota, which is the largest...

...Kai Hildner; Elise Punkenburg; Benjamin Abendroth; Markus F. Neurath Background: Inflammatory bowel diseases (IBDs) represent a group of chronic immune-mediated disorders that are influenced by a genetic predisposition and additional environmental triggers. Genome-wide association studies strongly...

...Raja Atreya; Markus F. Neurath Background: Different invasive and non-invasive imaging modalities are indispensable tools in the management of inflammatory bowel disease (IBD) patients. Standard imaging procedures like white light endoscopy or MRI are used to define gut inflammation based...

...Hans Herfarth; Andreas G. Schreyer Diagnostic imaging techniques play an important role in the diagnosis and management of patients with inflammatory bowel diseases (IBDs). The approach should be guided by considerations of diagnostic accuracy, concerns about patient exposure to ionizing radiation...

...Eytan Wine Background/Aim: It is now clear that intestinal microbes are involved in many aspects of inflammatory bowel diseases (IBD) and that understanding how microbes lead to disease could present novel opportunities for diagnosis and treatment. Microbes are linked to most disease-associated...

...Hans Herfarth Imaging is a central component of the diagnostic process in inflammatory bowel diseases. This review summarizes the recent progress of various most commonly used imaging modalities including computed tomography enterography, magnetic resonance enterography and capsule endoscopy...

...M. De Vos; L. Van Praet; D. Elewaut Osteoarticular manifestations in inflammatory bowel diseases (IBD) belong to the concept of spondyloarthritis (SpA) including an axial and peripheral SpA according to predominant symptoms (inflammatory back pain vs. peripheral arthritis and enthesopathy). Careful...

...Markus F. Neurath Background/Aims: Inflammatory bowel diseases (IBD) are chronic relapsing diseases of unknown origin. In spite of improved options for therapy, many patients with IBD have an impaired quality of life and require hospitalization or surgery. Animal models of IBD might help to obtain...

.... Inflammation Cancer Proteinases Tumor progression Matrix metalloproteinase Colorectal cancer Inflammatory bowel diseases Chronic inflammation is an important risk factor for the development of tumors. The link between inflammation and cancer was first described in the nineteenth century...

...Raja Atreya; M.F. Neurath Uncontrolled activation of mucosal effector cells has been identified as the main pathogenic mechanism involved in the initiation and perpetuation of mucosal inflammation in inflammatory bowel diseases (IBD). The sustained activation of these cells leads to the aberrant...